Comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 vs 4 5 Toe Cutaneous Syndactyly C5937268
Clinical comparison between 46 XX Disorder OF Sex Development Induced BY Fetal Androgens Excess and 4 5 Toe Cutaneous Syndactyly for differential diagnosis and treatment planning.
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
A condition where an XX fetus produces excess male hormones, often from adrenal gland abnormalities, leading to atypical genital development. It is identified at birth. Treatment typically includes hormone therapy and possible surgery.
4 5 Toe Cutaneous Syndactyly C5937268
Webbing between the 4th and 5th toes, present from birth. Usually mild and often does not affect walking. Treatment is typically not needed unless symptoms develop.
6 comparison axes
Onset
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
0-0
4 5 Toe Cutaneous Syndactyly C5937268
0-0
Onset patterns differ
Severity
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
severe
4 5 Toe Cutaneous Syndactyly C5937268
mild
Different severity levels
Chronic
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
Chronic
4 5 Toe Cutaneous Syndactyly C5937268
Chronic
Differing course
Communicable
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
No
4 5 Toe Cutaneous Syndactyly C5937268
No
Different transmission
Body System
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
reproductive
4 5 Toe Cutaneous Syndactyly C5937268
musculoskeletal
Same/different system
Category
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
endocrine
4 5 Toe Cutaneous Syndactyly C5937268
genetic
Different category
Bottom line
46-xx-disorder-of-sex-development-induced-by-fetal-androgens-excess-C5680189 and 4-5-toe-cutaneous-syndactyly-C5937268 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 4 5 Toe Cutaneous Syndactyly C5937268 | Discriminating power |
|---|---|---|---|
| Genital appearance | Atypical genital development may be recognized at birth. | Genital development is not part of this toe finding. | High |
| Toe webbing | Toe webbing is not a described feature. | Skin webbing joins the fourth and fifth toes from birth. | High |
| Walking | Walking is not the primary concern described. | Walking is usually unaffected unless symptoms develop. | Moderate |
When to favor each condition
Choose 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 when
Atypical genitalia in an XX infant
This pattern fits a disorder of sex development rather than a toe anomaly.
High
Suspected fetal androgen excess
Adrenal or other endocrine evaluation may be clinically relevant.
Moderate
Need for endocrine follow-up
Hormone therapy or surgery may be considered by specialists.
Moderate
Choose 4 5 Toe Cutaneous Syndactyly C5937268 when
Isolated fourth–fifth toe webbing
The finding is localized to the foot and usually mild.
High
Normal walking without pain
Treatment is often unnecessary when no symptoms develop.
Moderate
No genital or endocrine concern
This toe finding does not establish a sex-development disorder.
High
How key tests differ
| Test | 46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189 | 4 5 Toe Cutaneous Syndactyly C5937268 | Interpretation |
|---|---|---|---|
| Physical examination | Focuses on genital anatomy and associated features. | Shows cutaneous webbing between the fourth and fifth toes. | Exam location strongly separates the conditions. |
| Endocrine assessment | Hormone studies may be considered; no cutoff is established here. | Not routinely indicated for isolated toe webbing. | Abnormal hormones support, but do not alone diagnose, the left condition. |
| Genetic or imaging studies | Karyotype and targeted imaging may be used when clinically indicated. | Usually unnecessary unless another anomaly is suspected. | Testing should be individualized by a clinician. |
Prognosis comparison
46 Xx Disorder Of Sex Development Induced By Fetal Androgens Excess C5680189
- Outcome
- Often requires ongoing endocrine and developmental care; exact outcomes are not established here.
- Factors
- Cause, adrenal involvement, and individualized treatment decisions may influence course.
4 5 Toe Cutaneous Syndactyly C5937268
- Outcome
- Usually remains mild, with little effect on walking.
- Factors
- Pain, functional symptoms, or additional anomalies may change management.
Time frame: Both are present from birth and may be chronic, but their courses differ.
Prognosis should be interpreted by clinicians using the individual evaluation.
Complications comparison
| Complication | Presentation |
|---|---|
| Functional limitation | Potential effects relate to genital and endocrine development. Walking is usually preserved. Severity differs markedly in the supplied data. |
| Treatment burden | May involve hormone therapy and possible surgery. Treatment is typically unnecessary unless symptoms occur. Exact doses and procedures are not established here. |
| Associated conditions | Adrenal abnormalities are often implicated, but causes vary. Usually an isolated mild congenital finding. Broader syndromes should not be assumed without evaluation. |
Patient education highlights
- HighDifferent conditions
Atypical genital development and toe webbing are separate findings and should not be conflated.
- HighSpecialist care
Suspected disorder of sex development needs prompt specialist assessment; isolated toe webbing often needs observation.
- MediumWhen to seek review
Report pain, walking difficulty, new symptoms, or uncertainty about test results to a clinician.